Cosmetics firm pulls product after pressure from FDA, Allergan

01/6/2008 | Wall Street Journal (free content), The

Jan Marini Skin Research is withdrawing from the U.S. market an eyelash cosmetic after the FDA alleged an ingredient in the product is similar to a prescription drug. Meanwhile, Allergan, maker of glaucoma drug Lumigan, announced last week it was dropping one of seven defendants in its patent-infringement lawsuit against eyelash-product companies.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care